“Rheumatoid Factor Positivity Rather Than Anti-CCP Positivity, a Lower Disability and a Lower Number of Anti-TNFα Agents Failed Are Associated With Response to Rituximab in Rheumatoid Arthritis”. Reumatismo 61, no. 3 (September 30, 2009): 182–186. Accessed July 15, 2025. https://www.reumatismo.org/reuma/article/view/reumatismo.2009.182.